In this episode, Dr. Sergio Zanotti discusses arterial catheters in shock through the lens of the recently published EVERDAC trial. He is joined by Dr. Gregoire Muller, a critical care physician in the Department of Intensive Care Medicine and Resuscitation at the University Hospital Center of Orléans, Orléans, France. Dr. Muller is an accomplished clinician and researcher. He is the principal investigator/lead author of the EVERDAC clinical trial published in the New England Journal of Medicine.

Additional resources:

Deferring Arterial Catheterization in Critically Ill Patients with Shock. EVERDAC Trial. New Engl J Med 2025.

Arterial lines in the ICU: A call for rigorous controlled trials. CHEST 2014.

Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France 2006. Intensive Care Med 2007.

Noninvasive BP monitoring in the critically ill: time to abandon the arterial catheter? CHEST 2018. 

Books mentioned in this episode:

Getting Things Done: The Art of Stress-Free Productivity. By David Allen.